We led an investigation to decide if hypo fractionated 35-days timetable of entire breast radiation is pretty much as viable. Women who bearing obtrusive breast carcinoma had gone through breast monitoring a medical procedure and resection edges were clean and partially lymph hubs were negatively approached with haphazardly relegated to get entire bosom illumination either at a control portion of 50 Gy in 15 divisions over a time of 45 days or at a portion of 45.5 Gy in 12 parts over a time of 22 days (the hypo fractionated-radiation bunch). The repetition at 36 months were 7.2% among the 301 ladies allocated to standard illumination as contrasted and 7.6% among the 312 ladies allocated to the hypo fractionated routine. At 36 months, 69.5% of ladies in the benchmark group as contrasted and 71.2% of the ladies in the hypo fractionated-radiation bunch had a decent or astounding restorative result. 3 years after therapy, sped up, hypo fractionated entire breast illumination was not sub-par compared to standard radiation therapy in ladies who had gone through breast preserving a medical procedure for obtrusive bosom malignant growth with clear careful edges what's more, negative axillary hubs. The ideal fractionation plan for entire bosom light after bosom rationing medical procedure is obscure.

The study aimed to evaluate the treatment outcomes of single-channel and tri-channel applicators for cervical cancer patients based on high dose rate brachytherapy using an artificial neural network. An artificial neural network (ANNs) model is proposed to predict the treatment outcomes for the single-channel applicator and tri-channel applicator in cervical cancer for high dose rate brachytherapy. Fifty-four patients of cervical cancer who were receiving external beam radiation therapy (EBRT) of 40-50 cGy, with chemotherapy, were selected in this study from 37 patients with cervical cancer being used to train and 17 for testing in this model. A model was developed for intracavitary brachytherapy to estimate the comparison of　treatment outcomes for the single-channel applicator and tri-channel applicators, demonstrating the sensitivity 100% and specificity 100 % and accuracy 100% for training and 87.5%, 77.8%, and 82.4% for testing, respectively, including AUC= 0.961. The survival rate was 85% and 95% for single-channel and tri-channel applicators at 2 years, respectively. A model approach for artificial neural networks based on gynecological brachytherapy is a promising method for patient's treatment, resulting in the dosimetry output of applicators; medical physicists can be decided the appropriate applicator for cervical cancer. The proposed model has the potential accuracy in judging the treatment outcomes for the single-channel applicator and tri-channel applicator in cervical cancer based on survival analysis.

Background: Carcinoma cervix is a significant health concern, particularly in lower socioeconomic groups. The effectiveness of interdigitated versus sequential brachytherapy, both with concurrent chemoradiation, in treating this condition remains underexplored. Methods: This quasi-experimental study at Rajshahi Medical College Hospital enrolled 63 patients with biopsy-proven squamous cell cervical cancer. They were randomly divided into two arms: arm a received pelvic EBRT 50 Gy in 25 fractions, followed by HDR brachytherapy (7 Gy weekly × 3 weeks) starting after 30 Gy of EBRT; arm B received the same pelvic EBRT, followed by HDR brachytherapy (7 Gy weekly × 3 weeks) starting a week after the completion of EBRT. Results: Mean age was 47.82±8.45 years (range: 29-64 years). The mean OTT was significantly reduced in arm-A (36.58 days) compared to arm-B (59.5 days). In terms of treatment response, 90.32% of patients in arm-A and 78.12% in arm-B experienced a complete response. Conclusions: Interdigitated brachytherapy with concurrent chemoradiation significantly reduces treatment time without compromising treatment effectiveness. Despite a shorter treatment duration, the complete response rate was slightly higher in the interdigitated arm.

No abstract

No abstract